Mark Earl Hensley - Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Issuer Symbol
HRTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Earl Hensley since 13 Feb 2025

Holdings reported by Mark Earl Hensley for HERON THERAPEUTICS, INC. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Performance Stock Option (Right to Buy) 900,000 $1,980,000 $2.20 28 Apr 2025 Direct Common Stock 900,000
Employee Stock Option (Right to Buy) 500,000 $1,100,000 $2.20 28 Apr 2025 Direct Common Stock 500,000
Restricted Stock Units 188,315 30 Jan 2026 Direct Common Stock
Performance Stock Units 188,314 30 Jan 2026 Direct Common Stock

Transactions reported by Mark Earl Hensley for HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.